Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes
Authors:
- 6 June 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (9) , 1461-1471
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patientsJournal of Inherited Metabolic Disease, 2007
- Newborn screening for lysosomal storage disordersMolecular Genetics and Metabolism, 2006
- The ratio of α‐galactosidase to β‐glucuronidase activities in dried blood for the identification of female Fabry disease patientsJournal of Inherited Metabolic Disease, 2005
- Fabry disease in the era of enzyme replacement therapy: a renal perspectivePediatric Nephrology, 2004
- Fabry disease in childhoodThe Journal of Pediatrics, 2004
- α-l-Iduronidase Premature Stop Codons and Potential Read-Through in Mucopolysaccharidosis Type I PatientsJournal of Molecular Biology, 2004
- Fabry disease: Kidney involvement and enzyme replacement therapyKidney International, 2004
- The early clinical phenotype of Fabry disease: a study on 35 European children and adolescentsEuropean Journal of Pediatrics, 2003
- Hypertrophic cardiomyopathy in late‐onset variant of Fabry disease with high residual activity of α‐galactosidase AClinical Genetics, 1991
- Renal filtration, transport, and metabolism of low-molecular-weight proteins: A reviewKidney International, 1979